跳至主要内容
临床试验/JPRN-UMIN000006174
JPRN-UMIN000006174已完成未知

Goal-Oriented Therapy Evaluated By Cardiopulmonary Exercise Testing For Pulmonary Arterial Hypertension - GOOD EYE

Department of Cardiology, Nagoya University Graduate School of Medicine0 个研究点目标入组 129 人开始时间: 2011年8月15日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
129

研究概览

简要总结

The primary endpoint was cardiovascular death. In the goal-oriented therapy group, plasma brain natriuretic peptide, mean pulmonary arterial pressure, pulmonary vascular resistance, and 6-min walk test were significantly improved at 12 months compared with baseline. Survival in the goal-oriented therapy group at 1, 2, and 3 years (97.6%, 95.2%, and 86.0%, respectively) tended to be higher than that in the conventional empiric therapy group (P=0.082).

研究设计

研究类型
Observational

入排标准

年龄范围
16years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Pulmonary hypertension due to left heart disease, Pulmonary hypertension due to lung diseases and/or hypoxia, Chronic thromboembolic pulmonary hypertension 2) Pregnant 3) Moderate or severe hepatic failure patients 4) More than 2.0 mg/dl Serum creatinine levels 5) Severe interstitial lung disease 6) Coronary artery disease 7) The patients can not walk by themself. 8) The patients who have taken medications for PAH treatment drugs including the pill PGI2, endothelin receptor antagonists, phosphoesterase inhibitors-5, and intravenous epoprostenol 9) Inappropriate patients due to other reasons

研究者

发起方
Department of Cardiology, Nagoya University Graduate School of Medicine

相似试验